3-Chloro-5-iodo-2-methoxypyridine | 1261685-77-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 3-Chloro-5-iodo-2-methoxypyridine
• CAS: 1261685-77-1
• 化学式: C₆H₅ClINO
• 分子量: 269.47
• InChiKey: HIARVASSHYRTTJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  22.1
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• 3-benzoyl-2,4,5-substituted pyridine derivatives or salts thereof and bactericides containing the same
  申请人：Nishide Hisaya

  公开号：US20060089390A1

  公开（公告）日：2006-04-27

  To provide 3-benzoyl-2,4,5-substituted pyridine derivatives or their salts, fungicides containing them, and intermediates for producing them. By providing a group of compounds comprising specific 3-benzoyl-2,4,5-substituted pyridine derivatives or their salts, or fungicides containing them, which have so-called rainfastness, whereby they are capable of exhibiting excellent effects even when crops have received rainfall after application of the chemicals, it becomes unnecessary to increase the number of applications or the dose of the chemicals by taking into consideration the rainfall after the application of the chemicals. Thus, it is possible to protect crops from disease injuries at a lower cost with less labor.

  提供3-苯甲酰基-2,4,5-取代吡啶衍生物或其盐，含有它们的杀菌剂以及用于生产它们的中间体。通过提供一组化合物，其中包括特定的3-苯甲酰基-2,4,5-取代吡啶衍生物或其盐，或含有它们的杀菌剂，这些化合物具有所谓的雨水稳定性，即使作物在化学品施用后遭受降雨，它们仍能展现出优异的效果，因此不必考虑化学品施用后的降雨增加化学品的施用次数或剂量。因此，可以以更低的成本和更少的劳动力保护作物免受病害的伤害。
• [EN] 6-HETEROCYCLOALKYL-QUINAZOLINE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE 6-HÉTÉROCYCLOALKYLE-QUINAZOLINE ET LEURS UTILISATIONS
  申请人：BLACK DIAMOND THERAPEUTICS INC

  公开号：WO2022266458A1

  公开（公告）日：2022-12-22

  The present disclosure relates to compounds of Formula (I): and pharmaceutically acceptable salts and stereoisomers thereof, useful in the treatment of cancers associated with ErbB oncogenic activity, including methods of preparing the compounds, compositions comprising the compounds, and methods of using the compounds (e.g., in the treatment of cancer).

  本公开涉及式（I）的化合物及其药学上可接受的盐和立体异构体，用于治疗与ErbB致癌活性相关的癌症，包括制备该化合物的方法，包含该化合物的组合物，以及使用该化合物的方法（例如，用于治疗癌症）。
• Inhibitors of serine proteases
  申请人：VERTEX PHARMACEUTICALS INCORPORATED

  公开号：EP2366704B1

  公开（公告）日：2013-10-23